ReviewJournal of personalized medicine2022

Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer.

Michael J Duffy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.